In an effort to discover novel candidate proteins that may mediate immune evasion in cancer, we assessed the inverse correlation between expression of 614 frequently gained genes and IFNG, an antitumor gene expressed by immune effector cells, in 208 metastatic castration-resistant prostate cancer (mCRPC) samples [Fig. 1A (left)]. The gene discussed is IFNG; the disease is cancer.